Bid to delay three-week AFT Pharmaceuticals trial declined

Bid to delay three-week AFT Pharmaceuticals trial declined
AFT Pharmaceuticals' managing director Hartley Atkinson is claiming PBL Solutions is taking against the NZX-listed company. (Image: Supplied)
Riley Kennedy
AFT Pharmaceuticals will face off against a former joint venture partner after the high court rejected a bid to delay the dispute's hearing until 2024.In the high court at Auckland, Justice Geoffrey Venning affirmed a three-week hearing between AFT and British Virgin Islands-based PBL Solutions will take place in October this year, bringing their two-year-old dispute to a head. PBL sought to have the case pushed out by 12 months, although the courts wouldn't have been able to hear it before 2024.While the judge rejected the applica...

More Markets

NZ sharemarket steady despite US slump
Markets Market Close

NZ sharemarket steady despite US slump

Financial adviser says investors holding their breath for reporting season.

ASB's $35.5m mystery payout to customers
Markets

ASB's $35.5m mystery payout to customers

CBA reveals A$33m remediation provision for ASB customers ahead of A$10b expected result.

Strong lead from US carries NZX 50 up 1.5%
Markets Market Close

Strong lead from US carries NZX 50 up 1.5%

"Bad news is good news," one analyst said.

Gregor Thompson 05 Aug 2025